Back
Bio-Techne Corp (TECH)
Life Sciences Tools & ServicesTECH · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$72.33
−0.12%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$0.46
ROE
5.3%
Gross margin
66.4%
Debt/Equity
0.14x
Revenue growth
-1.5%
Bio-Techne Corp — company intelligence
Earnings surprises
Q3 2026$0.53 vs $0.55 est-3.3%
Q2 2026$0.46 vs $0.44 est+4.0%
Q1 2026$0.42 vs $0.43 est-2.0%
Q4 2025$0.53 vs $0.51 est+4.1%
Analyst consensus · 22 analysts
9 Buy13 Hold0 Sell
Updated Aug 11, 2026
Insider activity · 90 days
0 buys4 sellsnet -80,270 shares
Hippel JamesSell 51,024 · Jul 29, 2026
Hippel Jamesother 62,068 · Jul 29, 2026
Kelderman Kimother 35,000 · Jul 28, 2026
Recent SEC filings
4 — Insider transaction reportAug 19, 2026
4 — Insider transaction reportAug 19, 2026
4 — Insider transaction reportAug 19, 2026
Latest news
Is Wall Street Bullish or Bearish on Bio-Techne Stock? — Yahoo · 1w ago
3 High-Flying Stocks We Approach with Caution — Yahoo · 1w ago
Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73 — Benzinga · 1w ago
TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises — Yahoo · 1w ago
Bio-Techne Corrects Dividend Announcement — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.